News
12-31-2009, 04:14 AM
Bionovo, Inc. (Nasdaq: BNVI) announced the publication of results from its study on the anti-tumor mechanism of BN107. The results of the study, published in the International Journal of Cancer, describe the potential molecular mechanisms mediating the selective pro-apoptotic (cell death) effect induced by BN107 on estrogen receptor negative (ER-) breast cancer cells...
More... (http://mnt.to/f/3vRw)
More... (http://mnt.to/f/3vRw)